Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer

被引:3
|
作者
Marvaso, Giulia [1 ,2 ]
Volpe, Stefania [1 ,2 ]
Pepa, Matteo [1 ]
Zaffaroni, Mattia [1 ]
Corrao, Giulia [1 ,2 ]
Augugliaro, Matteo [1 ]
Nole, Franco [3 ]
De Cobelli, Ottavio [2 ,4 ]
Jereczek-Fossa, Barbara Alicja [1 ,2 ]
机构
[1] IEO European Inst Oncol IRCCS, Div Radiat Oncol, Milan, Italy
[2] Univ Milan, Dept Oncol & Hemato Oncol, Milan, Italy
[3] IEO European Inst Oncol IRCCS, Med Oncol, Div Urogenital Head Neck Tumors, Milan, Italy
[4] European Inst Oncol IRCCS, Dept Urol, IEO, Milan, Italy
来源
CANCER MANAGEMENT AND RESEARCH | 2022年 / 14卷
关键词
oligometastatic prostate cancer; metastasis-directed therapies; narrative review; imaging; biology; METASTASIS-DIRECTED THERAPY; CIRCULATING TUMOR-CELLS; FREE DNA; MICRORNAS; BIOLOGY; MIRNAS; MRI; DOCETAXEL; DISEASE; BLOOD;
D O I
10.2147/CMAR.S321136
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
After primary treatment for prostate cancer with either radical prostatectomy or radiotherapy, a significant proportion of patients are at risk of developing metastases. In recent years, a deeper understanding of the underlying biology together with improved imaging techniques and the advent of new therapeutic options including metastases-directed therapies and new drugs have revolutionized the management of low-burden meta-static disease, also known as oligometastatic state. The purpose of this narrative review is to report the recent developments in the management of hormone-sensitive oligometastatic prostate cancer patients.
引用
收藏
页码:89 / 101
页数:13
相关论文
共 50 条
  • [1] Management of Oligometastatic Hormone-Sensitive Prostate Cancer
    Tran, Phuoc T.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (08) : 370 - 373
  • [2] Trends in Management of Oligometastatic Hormone-Sensitive Prostate Cancer
    Kothari, Gargi
    Ost, Piet
    Cheung, Patrick
    Blanchard, Pierre
    Tree, Alison C.
    van As, Nicholas J.
    Lo, Simon S.
    Moghanaki, Drew
    Loblaw, Andrew
    Siva, Shankar
    CURRENT ONCOLOGY REPORTS, 2019, 21 (05)
  • [3] Trends in Management of Oligometastatic Hormone-Sensitive Prostate Cancer
    Gargi Kothari
    Piet Ost
    Patrick Cheung
    Pierre Blanchard
    Alison C. Tree
    Nicholas J. van As
    Simon S. Lo
    Drew Moghanaki
    Andrew Loblaw
    Shankar Siva
    Current Oncology Reports, 2019, 21
  • [4] Developments in oligometastatic hormone-sensitive prostate cancer
    Chow, Ken
    Mccoy, Patrick
    Stuchbery, Ryan
    Corcoran, Niall M.
    Hovens, Christopher M.
    WORLD JOURNAL OF UROLOGY, 2019, 37 (12) : 2549 - 2555
  • [5] Developments in oligometastatic hormone-sensitive prostate cancer
    Ken Chow
    Patrick McCoy
    Ryan Stuchbery
    Niall M. Corcoran
    Christopher M. Hovens
    World Journal of Urology, 2019, 37 : 2549 - 2555
  • [6] Developments in oligometastatic hormone-sensitive prostate cancer
    Phuoc T. Tran
    Piet Ost
    World Journal of Urology, 2019, 37 : 2545 - 2547
  • [7] Evolving Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer
    Clement, Jessica M.
    Sweeney, Christopher J.
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (01) : 9 - +
  • [8] The role of radiotherapy in oligometastatic hormone-sensitive prostate cancer
    Abdel-Aty, Hoda
    James, Nicholas D.
    CURRENT OPINION IN UROLOGY, 2022, 32 (03) : 277 - 282
  • [9] Local therapies for oligometastatic hormone-sensitive prostate cancer
    Falkenbach, Fabian
    Steuber, Thomas
    Graefen, Markus
    UROLOGIE, 2024, 63 (03): : 234 - 240
  • [10] Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer: A Comprehensive Review
    Koo, Kyo Chul
    Dasgupta, Prokar
    YONSEI MEDICAL JOURNAL, 2018, 59 (05) : 567 - 579